SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-036831
Filing Date
2022-11-22
Accepted
2022-11-22 21:45:28
Documents
2
Period of Report
2022-11-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7350
2 EX-24 DOCUMENT attachment1.htm EX-24 4888
  Complete submission text file 0000899243-22-036831.txt   13851
Mailing Address 1 BROADWAY, 7TH FLOOR, SUITE 07-300 CAMBRIDGE MA 02142
Business Address 1 BROADWAY, 7TH FLOOR, SUITE 07-300 CAMBRIDGE MA 02142 857-254-4445
Vigil Neuroscience, Inc. (Issuer) CIK: 0001827087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ADAMAS PHARMACEUTICALS, INC. 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address
Papapetropoulos Spyros (Reporting) CIK: 0001832694 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41200 | Film No.: 221412146